img

Global Musculoskeletal Disorder Stem Cell Therapy Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Musculoskeletal Disorder Stem Cell Therapy Market Research Report 2024

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. This report studies on the Musculoskeletal Disorder Stem Cell Therapy.
According to Mr Accuracy reports’s new survey, global Musculoskeletal Disorder Stem Cell Therapy market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Musculoskeletal Disorder Stem Cell Therapy market research.
Key companies engaged in the Musculoskeletal Disorder Stem Cell Therapy industry include Osiris Therapeutics, NuVasive, Takeda (TiGenix) and Medi-post, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Musculoskeletal Disorder Stem Cell Therapy were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Musculoskeletal Disorder Stem Cell Therapy market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Musculoskeletal Disorder Stem Cell Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Osiris Therapeutics
NuVasive
Takeda (TiGenix)
Medi-post
Segment by Type
Allogeneic
Autologous

Segment by Application


Muscle disease
Skeletal disease
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Musculoskeletal Disorder Stem Cell Therapy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Musculoskeletal Disorder Stem Cell Therapy Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Allogeneic
1.2.3 Autologous
1.3 Market by Application
1.3.1 Global Musculoskeletal Disorder Stem Cell Therapy Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Muscle disease
1.3.3 Skeletal disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Musculoskeletal Disorder Stem Cell Therapy Market Perspective (2018-2034)
2.2 Musculoskeletal Disorder Stem Cell Therapy Growth Trends by Region
2.2.1 Global Musculoskeletal Disorder Stem Cell Therapy Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Musculoskeletal Disorder Stem Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Musculoskeletal Disorder Stem Cell Therapy Forecasted Market Size by Region (2024-2034)
2.3 Musculoskeletal Disorder Stem Cell Therapy Market Dynamics
2.3.1 Musculoskeletal Disorder Stem Cell Therapy Industry Trends
2.3.2 Musculoskeletal Disorder Stem Cell Therapy Market Drivers
2.3.3 Musculoskeletal Disorder Stem Cell Therapy Market Challenges
2.3.4 Musculoskeletal Disorder Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Musculoskeletal Disorder Stem Cell Therapy Players by Revenue
3.1.1 Global Top Musculoskeletal Disorder Stem Cell Therapy Players by Revenue (2018-2023)
3.1.2 Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Musculoskeletal Disorder Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Musculoskeletal Disorder Stem Cell Therapy Revenue
3.4 Global Musculoskeletal Disorder Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Musculoskeletal Disorder Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal Disorder Stem Cell Therapy Revenue in 2024
3.5 Musculoskeletal Disorder Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Musculoskeletal Disorder Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Musculoskeletal Disorder Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Musculoskeletal Disorder Stem Cell Therapy Breakdown Data by Type
4.1 Global Musculoskeletal Disorder Stem Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Musculoskeletal Disorder Stem Cell Therapy Forecasted Market Size by Type (2024-2034)
5 Musculoskeletal Disorder Stem Cell Therapy Breakdown Data by Application
5.1 Global Musculoskeletal Disorder Stem Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Musculoskeletal Disorder Stem Cell Therapy Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Musculoskeletal Disorder Stem Cell Therapy Market Size (2018-2034)
6.2 North America Musculoskeletal Disorder Stem Cell Therapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2018-2023)
6.4 North America Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Musculoskeletal Disorder Stem Cell Therapy Market Size (2018-2034)
7.2 Europe Musculoskeletal Disorder Stem Cell Therapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2018-2023)
7.4 Europe Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Market Size (2018-2034)
8.2 Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Musculoskeletal Disorder Stem Cell Therapy Market Size (2018-2034)
9.2 Latin America Musculoskeletal Disorder Stem Cell Therapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2018-2023)
9.4 Latin America Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Musculoskeletal Disorder Stem Cell Therapy Market Size (2018-2034)
10.2 Middle East & Africa Musculoskeletal Disorder Stem Cell Therapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Osiris Therapeutics
11.1.1 Osiris Therapeutics Company Detail
11.1.2 Osiris Therapeutics Business Overview
11.1.3 Osiris Therapeutics Musculoskeletal Disorder Stem Cell Therapy Introduction
11.1.4 Osiris Therapeutics Revenue in Musculoskeletal Disorder Stem Cell Therapy Business (2018-2023)
11.1.5 Osiris Therapeutics Recent Development
11.2 NuVasive
11.2.1 NuVasive Company Detail
11.2.2 NuVasive Business Overview
11.2.3 NuVasive Musculoskeletal Disorder Stem Cell Therapy Introduction
11.2.4 NuVasive Revenue in Musculoskeletal Disorder Stem Cell Therapy Business (2018-2023)
11.2.5 NuVasive Recent Development
11.3 Takeda (TiGenix)
11.3.1 Takeda (TiGenix) Company Detail
11.3.2 Takeda (TiGenix) Business Overview
11.3.3 Takeda (TiGenix) Musculoskeletal Disorder Stem Cell Therapy Introduction
11.3.4 Takeda (TiGenix) Revenue in Musculoskeletal Disorder Stem Cell Therapy Business (2018-2023)
11.3.5 Takeda (TiGenix) Recent Development
11.4 Medi-post
11.4.1 Medi-post Company Detail
11.4.2 Medi-post Business Overview
11.4.3 Medi-post Musculoskeletal Disorder Stem Cell Therapy Introduction
11.4.4 Medi-post Revenue in Musculoskeletal Disorder Stem Cell Therapy Business (2018-2023)
11.4.5 Medi-post Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Musculoskeletal Disorder Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Allogeneic
Table 3. Key Players of Autologous
Table 4. Global Musculoskeletal Disorder Stem Cell Therapy Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Musculoskeletal Disorder Stem Cell Therapy Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Musculoskeletal Disorder Stem Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Musculoskeletal Disorder Stem Cell Therapy Market Share by Region (2018-2023)
Table 8. Global Musculoskeletal Disorder Stem Cell Therapy Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Musculoskeletal Disorder Stem Cell Therapy Market Share by Region (2024-2034)
Table 10. Musculoskeletal Disorder Stem Cell Therapy Market Trends
Table 11. Musculoskeletal Disorder Stem Cell Therapy Market Drivers
Table 12. Musculoskeletal Disorder Stem Cell Therapy Market Challenges
Table 13. Musculoskeletal Disorder Stem Cell Therapy Market Restraints
Table 14. Global Musculoskeletal Disorder Stem Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Musculoskeletal Disorder Stem Cell Therapy Market Share by Players (2018-2023)
Table 16. Global Top Musculoskeletal Disorder Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorder Stem Cell Therapy as of 2024)
Table 17. Ranking of Global Top Musculoskeletal Disorder Stem Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Musculoskeletal Disorder Stem Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Musculoskeletal Disorder Stem Cell Therapy Product Solution and Service
Table 21. Date of Enter into Musculoskeletal Disorder Stem Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Musculoskeletal Disorder Stem Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Musculoskeletal Disorder Stem Cell Therapy Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Type (2024-2034)
Table 27. Global Musculoskeletal Disorder Stem Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global Musculoskeletal Disorder Stem Cell Therapy Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Application (2024-2034)
Table 31. North America Musculoskeletal Disorder Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Musculoskeletal Disorder Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Musculoskeletal Disorder Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Musculoskeletal Disorder Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Musculoskeletal Disorder Stem Cell Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 46. Osiris Therapeutics Company Detail
Table 47. Osiris Therapeutics Business Overview
Table 48. Osiris Therapeutics Musculoskeletal Disorder Stem Cell Therapy Product
Table 49. Osiris Therapeutics Revenue in Musculoskeletal Disorder Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 50. Osiris Therapeutics Recent Development
Table 51. NuVasive Company Detail
Table 52. NuVasive Business Overview
Table 53. NuVasive Musculoskeletal Disorder Stem Cell Therapy Product
Table 54. NuVasive Revenue in Musculoskeletal Disorder Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 55. NuVasive Recent Development
Table 56. Takeda (TiGenix) Company Detail
Table 57. Takeda (TiGenix) Business Overview
Table 58. Takeda (TiGenix) Musculoskeletal Disorder Stem Cell Therapy Product
Table 59. Takeda (TiGenix) Revenue in Musculoskeletal Disorder Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 60. Takeda (TiGenix) Recent Development
Table 61. Medi-post Company Detail
Table 62. Medi-post Business Overview
Table 63. Medi-post Musculoskeletal Disorder Stem Cell Therapy Product
Table 64. Medi-post Revenue in Musculoskeletal Disorder Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 65. Medi-post Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Musculoskeletal Disorder Stem Cell Therapy Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Musculoskeletal Disorder Stem Cell Therapy Market Share by Type: 2024 VS 2034
Figure 3. Allogeneic Features
Figure 4. Autologous Features
Figure 5. Global Musculoskeletal Disorder Stem Cell Therapy Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Musculoskeletal Disorder Stem Cell Therapy Market Share by Application: 2024 VS 2034
Figure 7. Muscle disease Case Studies
Figure 8. Skeletal disease Case Studies
Figure 9. Musculoskeletal Disorder Stem Cell Therapy Report Years Considered
Figure 10. Global Musculoskeletal Disorder Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 11. Global Musculoskeletal Disorder Stem Cell Therapy Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Musculoskeletal Disorder Stem Cell Therapy Market Share by Region: 2024 VS 2034
Figure 13. Global Musculoskeletal Disorder Stem Cell Therapy Market Share by Players in 2024
Figure 14. Global Top Musculoskeletal Disorder Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorder Stem Cell Therapy as of 2024)
Figure 15. The Top 10 and 5 Players Market Share by Musculoskeletal Disorder Stem Cell Therapy Revenue in 2024
Figure 16. North America Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 17. North America Musculoskeletal Disorder Stem Cell Therapy Market Share by Country (2018-2034)
Figure 18. United States Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. Canada Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Europe Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe Musculoskeletal Disorder Stem Cell Therapy Market Share by Country (2018-2034)
Figure 22. Germany Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. France Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. U.K. Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Italy Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Russia Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Nordic Countries Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Market Share by Region (2018-2034)
Figure 30. China Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Japan Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. South Korea Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Southeast Asia Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. India Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Australia Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Latin America Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America Musculoskeletal Disorder Stem Cell Therapy Market Share by Country (2018-2034)
Figure 38. Mexico Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Brazil Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Middle East & Africa Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa Musculoskeletal Disorder Stem Cell Therapy Market Share by Country (2018-2034)
Figure 42. Turkey Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Saudi Arabia Musculoskeletal Disorder Stem Cell Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Osiris Therapeutics Revenue Growth Rate in Musculoskeletal Disorder Stem Cell Therapy Business (2018-2023)
Figure 45. NuVasive Revenue Growth Rate in Musculoskeletal Disorder Stem Cell Therapy Business (2018-2023)
Figure 46. Takeda (TiGenix) Revenue Growth Rate in Musculoskeletal Disorder Stem Cell Therapy Business (2018-2023)
Figure 47. Medi-post Revenue Growth Rate in Musculoskeletal Disorder Stem Cell Therapy Business (2018-2023)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries